Real-Life Effectiveness After Switching to Avalglucosidase Alfa in Late-Onset Pompe Disease Patients Worsening on Alglucosidase Alfa Therapy: A French Cohort Study.
Saved in:
| Title: | Real-Life Effectiveness After Switching to Avalglucosidase Alfa in Late-Onset Pompe Disease Patients Worsening on Alglucosidase Alfa Therapy: A French Cohort Study. |
|---|---|
| Authors: | Tard C; Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience and Cognition, University of Lille, Lille, France.; Centre de Référence Des Maladies NeuroMusculaires Nord - Est - Ile-de-France, Filnemus, Garches, France., Sacconi S; Centre Hospitalier Universitaire de Nice, Système Nerveux Périphérique and Muscle, Hôpital Pasteur 2, Université Côte D'azur, Nice, France., Taouagh N; Centre de Référence Des Maladies NeuroMusculaires Nord - Est - Ile-de-France, Filnemus, Garches, France.; Neurology Department, APHP, Raymond Poincaré University Hospital, FHU PHENIX, Garches, France., Bouhour F; Referral Centre for Neuromuscular Diseases, ENMG and Neuromuscular Disease Unit, Hopital Neurologique, Hospices Civils de Lyon, Lyon, France.; Centre de Référence Des Maladies NeuroMusculaires PACA Réunion Rhône Alpes, Filnemus, Marseille, France., Michaud M; Centre de Référence Des Maladies NeuroMusculaires Nord - Est - Ile-de-France, Filnemus, Garches, France.; Service de Neurologie, CHU de Nancy, Nancy, France., Beltran S; Service de Neurologie, CHRU Bretonneau, Tours, France., Fournier M; Centre de Référence Des Maladies NeuroMusculaires Nord - Est - Ile-de-France, Filnemus, Garches, France.; CHU de Caen, Caen, France., Demurger F; Service de Génétique, CHBA, Vannes, France., Lagrange E; Rare Neuromuscular Disease Center EFSN Neurology Grenoble University Alpes Hospital, Grenoble, France., Nollet S; Centre de Référence Des Maladies NeuroMusculaires Nord - Est - Ile-de-France, Filnemus, Garches, France.; Neurologie Electrophysiologie Clinique, CHRU Besançon, Besançon, France., Noury JB; Centre de Référence Des Maladies NeuroMusculaires AOC, Filnemus, Bordeaux, France.; Inserm, LBAI, UMR1227, CHRU de Brest, Brest, France., Magot A; Centre de Référence Des Maladies NeuroMusculaires AOC, Filnemus, Bordeaux, France.; Euro-NMD, CHU de Nantes, Nantes, France., Cintas P; CHU Toulouse, Toulouse, France., Renard D; Centre de Référence Des Maladies NeuroMusculaires AOC, Filnemus, Bordeaux, France.; CHU Nîmes, Université Montpellier, Montpellier, France., Deibener-Kaminsky J; Service de Médecine Interne et Immunologie Clinique, CHU Nancy Brabois, Vandœuvre-lès-Nancy, France., Lefeuvre C; Centre de Référence Des Maladies NeuroMusculaires Nord - Est - Ile-de-France, Filnemus, Garches, France.; Neurology Department, APHP, Raymond Poincaré University Hospital, FHU PHENIX, Garches, France., Davion JB; Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience and Cognition, University of Lille, Lille, France.; Centre de Référence Des Maladies NeuroMusculaires Nord - Est - Ile-de-France, Filnemus, Garches, France., Salort-Campana E; Centre de Référence Des Maladies NeuroMusculaires PACA Réunion Rhône Alpes, Filnemus, Marseille, France.; Service de Neurologie du Professeur Attarian, ERN Neuro-NMD, La Timone, Marseille, France., Arrassi A; Institut de Myologie, Hôpital La Pitié-Salpétrière, FHU PHENIX, AP-HP, Paris, France., Spinazzi M; Neuromuscular Reference Center, Department of Neurology, CHU D'angers, Angers, France., Hamroun D; Centre Hospitalo-Universitaire de Montpellier, Direction de la Recherche et de L'innovation, Montpellier, France., Chitimus D; INSERM U 1179, Handicap Neuromusculaire, UVSQ Paris-Saclay, Garches, France.; Doctoral School of Carol Davila University of Medicine and Pharmacy, Bucharest, Romania., Attarian S; Centre de Référence Des Maladies NeuroMusculaires PACA Réunion Rhône Alpes, Filnemus, Marseille, France.; Service de Neurologie du Professeur Attarian, ERN Neuro-NMD, La Timone, Marseille, France., Laforêt P; Centre de Référence Des Maladies NeuroMusculaires Nord - Est - Ile-de-France, Filnemus, Garches, France.; Neurology Department, APHP, Raymond Poincaré University Hospital, FHU PHENIX, Garches, France. |
| Corporate Authors: | Pompe Study Group |
| Source: | European journal of neurology [Eur J Neurol] 2026 Jul; Vol. 33 (7), pp. e70680. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley Country of Publication: England NLM ID: 9506311 Publication Model: Print Cited Medium: Internet ISSN: 1468-1331 (Electronic) Linking ISSN: 13515101 NLM ISO Abbreviation: Eur J Neurol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42462098 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Real-Life Effectiveness After Switching to Avalglucosidase Alfa in Late-Onset Pompe Disease Patients Worsening on Alglucosidase Alfa Therapy: A French Cohort Study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Tard+C%22">Tard C</searchLink>; Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience and Cognition, University of Lille, Lille, France.; Centre de Référence Des Maladies NeuroMusculaires Nord - Est - Ile-de-France, Filnemus, Garches, France.<br /><searchLink fieldCode="AU" term="%22Sacconi+S%22">Sacconi S</searchLink>; Centre Hospitalier Universitaire de Nice, Système Nerveux Périphérique and Muscle, Hôpital Pasteur 2, Université Côte D'azur, Nice, France.<br /><searchLink fieldCode="AU" term="%22Taouagh+N%22">Taouagh N</searchLink>; Centre de Référence Des Maladies NeuroMusculaires Nord - Est - Ile-de-France, Filnemus, Garches, France.; Neurology Department, APHP, Raymond Poincaré University Hospital, FHU PHENIX, Garches, France.<br /><searchLink fieldCode="AU" term="%22Bouhour+F%22">Bouhour F</searchLink>; Referral Centre for Neuromuscular Diseases, ENMG and Neuromuscular Disease Unit, Hopital Neurologique, Hospices Civils de Lyon, Lyon, France.; Centre de Référence Des Maladies NeuroMusculaires PACA Réunion Rhône Alpes, Filnemus, Marseille, France.<br /><searchLink fieldCode="AU" term="%22Michaud+M%22">Michaud M</searchLink>; Centre de Référence Des Maladies NeuroMusculaires Nord - Est - Ile-de-France, Filnemus, Garches, France.; Service de Neurologie, CHU de Nancy, Nancy, France.<br /><searchLink fieldCode="AU" term="%22Beltran+S%22">Beltran S</searchLink>; Service de Neurologie, CHRU Bretonneau, Tours, France.<br /><searchLink fieldCode="AU" term="%22Fournier+M%22">Fournier M</searchLink>; Centre de Référence Des Maladies NeuroMusculaires Nord - Est - Ile-de-France, Filnemus, Garches, France.; CHU de Caen, Caen, France.<br /><searchLink fieldCode="AU" term="%22Demurger+F%22">Demurger F</searchLink>; Service de Génétique, CHBA, Vannes, France.<br /><searchLink fieldCode="AU" term="%22Lagrange+E%22">Lagrange E</searchLink>; Rare Neuromuscular Disease Center EFSN Neurology Grenoble University Alpes Hospital, Grenoble, France.<br /><searchLink fieldCode="AU" term="%22Nollet+S%22">Nollet S</searchLink>; Centre de Référence Des Maladies NeuroMusculaires Nord - Est - Ile-de-France, Filnemus, Garches, France.; Neurologie Electrophysiologie Clinique, CHRU Besançon, Besançon, France.<br /><searchLink fieldCode="AU" term="%22Noury+JB%22">Noury JB</searchLink>; Centre de Référence Des Maladies NeuroMusculaires AOC, Filnemus, Bordeaux, France.; Inserm, LBAI, UMR1227, CHRU de Brest, Brest, France.<br /><searchLink fieldCode="AU" term="%22Magot+A%22">Magot A</searchLink>; Centre de Référence Des Maladies NeuroMusculaires AOC, Filnemus, Bordeaux, France.; Euro-NMD, CHU de Nantes, Nantes, France.<br /><searchLink fieldCode="AU" term="%22Cintas+P%22">Cintas P</searchLink>; CHU Toulouse, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Renard+D%22">Renard D</searchLink>; Centre de Référence Des Maladies NeuroMusculaires AOC, Filnemus, Bordeaux, France.; CHU Nîmes, Université Montpellier, Montpellier, France.<br /><searchLink fieldCode="AU" term="%22Deibener-Kaminsky+J%22">Deibener-Kaminsky J</searchLink>; Service de Médecine Interne et Immunologie Clinique, CHU Nancy Brabois, Vandœuvre-lès-Nancy, France.<br /><searchLink fieldCode="AU" term="%22Lefeuvre+C%22">Lefeuvre C</searchLink>; Centre de Référence Des Maladies NeuroMusculaires Nord - Est - Ile-de-France, Filnemus, Garches, France.; Neurology Department, APHP, Raymond Poincaré University Hospital, FHU PHENIX, Garches, France.<br /><searchLink fieldCode="AU" term="%22Davion+JB%22">Davion JB</searchLink>; Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience and Cognition, University of Lille, Lille, France.; Centre de Référence Des Maladies NeuroMusculaires Nord - Est - Ile-de-France, Filnemus, Garches, France.<br /><searchLink fieldCode="AU" term="%22Salort-Campana+E%22">Salort-Campana E</searchLink>; Centre de Référence Des Maladies NeuroMusculaires PACA Réunion Rhône Alpes, Filnemus, Marseille, France.; Service de Neurologie du Professeur Attarian, ERN Neuro-NMD, La Timone, Marseille, France.<br /><searchLink fieldCode="AU" term="%22Arrassi+A%22">Arrassi A</searchLink>; Institut de Myologie, Hôpital La Pitié-Salpétrière, FHU PHENIX, AP-HP, Paris, France.<br /><searchLink fieldCode="AU" term="%22Spinazzi+M%22">Spinazzi M</searchLink>; Neuromuscular Reference Center, Department of Neurology, CHU D'angers, Angers, France.<br /><searchLink fieldCode="AU" term="%22Hamroun+D%22">Hamroun D</searchLink>; Centre Hospitalo-Universitaire de Montpellier, Direction de la Recherche et de L'innovation, Montpellier, France.<br /><searchLink fieldCode="AU" term="%22Chitimus+D%22">Chitimus D</searchLink>; INSERM U 1179, Handicap Neuromusculaire, UVSQ Paris-Saclay, Garches, France.; Doctoral School of Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.<br /><searchLink fieldCode="AU" term="%22Attarian+S%22">Attarian S</searchLink>; Centre de Référence Des Maladies NeuroMusculaires PACA Réunion Rhône Alpes, Filnemus, Marseille, France.; Service de Neurologie du Professeur Attarian, ERN Neuro-NMD, La Timone, Marseille, France.<br /><searchLink fieldCode="AU" term="%22Laforêt+P%22">Laforêt P</searchLink>; Centre de Référence Des Maladies NeuroMusculaires Nord - Est - Ile-de-France, Filnemus, Garches, France.; Neurology Department, APHP, Raymond Poincaré University Hospital, FHU PHENIX, Garches, France. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22Pompe+Study+Group%22">Pompe Study Group</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229506311%22">European journal of neurology</searchLink> [Eur J Neurol] 2026 Jul; Vol. 33 (7), pp. e70680. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9506311 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1468-1331 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2213515101%22">13515101 </searchLink><i>NLM ISO Abbreviation: </i>Eur J Neurol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42462098 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1111/ene.70680 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e70680 Titles: – TitleFull: Real-Life Effectiveness After Switching to Avalglucosidase Alfa in Late-Onset Pompe Disease Patients Worsening on Alglucosidase Alfa Therapy: A French Cohort Study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Tard C – PersonEntity: Name: NameFull: Sacconi S – PersonEntity: Name: NameFull: Taouagh N – PersonEntity: Name: NameFull: Bouhour F – PersonEntity: Name: NameFull: Michaud M – PersonEntity: Name: NameFull: Beltran S – PersonEntity: Name: NameFull: Fournier M – PersonEntity: Name: NameFull: Demurger F – PersonEntity: Name: NameFull: Lagrange E – PersonEntity: Name: NameFull: Nollet S – PersonEntity: Name: NameFull: Noury JB – PersonEntity: Name: NameFull: Magot A – PersonEntity: Name: NameFull: Cintas P – PersonEntity: Name: NameFull: Renard D – PersonEntity: Name: NameFull: Deibener-Kaminsky J – PersonEntity: Name: NameFull: Lefeuvre C – PersonEntity: Name: NameFull: Davion JB – PersonEntity: Name: NameFull: Salort-Campana E – PersonEntity: Name: NameFull: Arrassi A – PersonEntity: Name: NameFull: Spinazzi M – PersonEntity: Name: NameFull: Hamroun D – PersonEntity: Name: NameFull: Chitimus D – PersonEntity: Name: NameFull: Attarian S – PersonEntity: Name: NameFull: Laforêt P IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 07 Text: 2026 Jul Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1468-1331 Numbering: – Type: volume Value: 33 – Type: issue Value: 7 Titles: – TitleFull: European journal of neurology Type: main |
| ResultId | 1 |